Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (32)	7/15/1998 1:36:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1475

Oooooh. Cool. Now, clear evidence of efficacy. Responses, some complete, in graft-versus-host disease (GvHD) in bone marrow transplant patients unresponsive to steroid therapy...... for those who don't know this disease, this is a remarkably difficult model. This will start the "logic ball" rolling.... phase II data.... a molecule that, if humanization was massaged as planned, could address virtually all of autoimmunity...... I can't believe how stupid some investors have been in the current "flight from biotech". The individual(s) selling BTRN are the numb-skulls of the bunch.